LLY · News · 20260824N

Product Launch - Foundayo

ELI LILLY & Co · 2026-08-24 · Importance 31 · Surprise 42

Eli Lilly launched its once-daily oral weight-loss and type 2 diabetes pill Foundayo (orforglipron) in the United Kingdom, its first European market. The product is available through private prescriptions for adults with a body-mass index of at least 30, or 27 to 30 with a weight-related health condition. Foundayo is priced below Lilly’s Mounjaro injection, while Lilly is discussing potential NHS availability with NICE, broadening its prospective access beyond private-pay channels.

Key facts